The 2026 Integrative Medicine MCAS Treatment Guide
- Mast cells sit at the crossroads of the immune system, the gut, the nervous system and connective tissue — so MCAS rarely travels alone.
- It commonly overlaps with EDS, POTS, fibromyalgia, IBS, chronic fatigue, long COVID, anxiety and neurodivergence.
- The integrative approach treats the whole picture under one coordinated plan, rather than one symptom at a time in separate clinics.
- Functional testing to find hidden triggers such as mould, stealth infections and gut dysbiosis.
- A therapeutic diet, staged to expand over time alongside gut repair.
- Mast cell stabilising nutraceuticals, and cannabinoid medicine where appropriate.
- Nervous system regulation, plus environment and mould work.
- Carefully titrated medication, matched to your level of sensitivity.
The integrative medicine approach to MCAS treatment
Integrative medicine treats Mast Cell Activation Syndrome as what it is — a whole-body, neuro-immune condition, not a collection of unrelated allergies. Rather than suppressing flares with antihistamines and hoping for the best, it looks at the mast cell system, the gut-brain-immune axis, the autonomic nervous system, the endocannabinoid system and hidden triggers like mould and stealth infections together, and stacks treatments so the whole plan works better than the sum of its parts. This is the Integrative Medicine MCAS Treatment Guide: what we commonly find when we assess someone properly, and what we most often see help — including the natural, functional and medical options standard care rarely brings together.
- What MCAS is & why it’s missed
- MCAS as a chronic, invisible illness
- What causes MCAS
- Conditions that travel with MCAS
- Functional medicine & testing
- Diet & the gut microbiome
- Nervous system & mindbody medicine
- Activity, pacing & rehabilitation
- Supplements & nutraceuticals
- Medication management
- Your environment & MCAS
- MCAS across the lifespan
- A patient journey
- Frequently asked questions
What MCAS is, and why it’s so often missed
Mast Cell Activation Syndrome is a condition in which mast cells — immune cells found throughout the body — release their chemical mediators such as histamine, tryptase and inflammatory cytokines inappropriately and repeatedly. Because mast cells line the gut, skin, airways, blood vessels and nervous system, the result is a bewildering, multi-system pattern of symptoms: flushing, hives and itching, unexplained allergic-type reactions, food and chemical sensitivities, reflux and bloating, palpitations, headaches, fatigue, brain fog and anxiety-like surges.
MCAS is frequently missed because it does not behave like a classic allergy. Standard allergy testing often comes back normal, since the problem is over-reactive mast cells rather than a single IgE trigger. Many of our patients have had their condition dismissed entirely, or been told their symptoms are “just anxiety”. Seeing the whole pattern — rather than one symptom at a time in one clinic at a time — is usually the difference between going round in circles and getting control.
MCAS as a chronic, invisible illness
MCAS is an “invisible” illness. From the outside a person can look completely well while living in constant vigilance about the next reaction — to a food, a scent, a medication, a change in temperature or a stressful day. The common experience is a life that shrinks: retreating to a tiny number of “safe” foods, avoiding restaurants and social events, and controlling the sensory environment to try to stay stable.
This is exhausting, and it is rarely understood. Many people with MCAS also carry other labels — IBS, chronic fatigue, anxiety, fibromyalgia, “post-viral” symptoms — that are treated in isolation by different specialists who never see the whole picture. Without looking at these together it is very hard to get control of any of them, because each one keeps the others going: flares trigger nervous-system stress, which triggers more mast cell activation; diet restriction leads to nutrient depletion that weakens immune regulation; gut dysbiosis drives histamine production. A holistic approach is designed to break that cycle so life can expand back out.
What causes MCAS: the integrative medicine view
MCAS is a disorder of mast cell regulation rather than mast cell number, and in most people it is driven not by one cause but by several overlapping ones. Common drivers we look for include a background of connective tissue laxity (hypermobility and hEDS), autonomic nervous system dysfunction, gut dysbiosis and increased intestinal permeability, hidden mould and mycotoxin exposure, stealth infections, and errors in the methylation pathway that impair histamine clearance or in the DAO enzyme that breaks histamine down.
A precipitating event — very often a viral infection, and increasingly COVID — can “tip” a susceptible system into full MCAS. Mast cell mediators cross the blood-brain barrier and drive neuroinflammation, which is why anxiety, panic and low mood are so often part of the picture rather than the cause of it. Cannabinoids act through the endocannabinoid system, which is closely linked to immune regulation, which helps explain why this system is a useful treatment target. Importantly, MCAS is not a psychosomatic condition; it has a clear biological basis, and there is a strong association with neurodivergence — recent research suggests mast cell activation may be present in a meaningful proportion of autistic and ADHD individuals.
The conditions that travel with MCAS: EDS, POTS and more
MCAS is almost never an isolated condition. The mast cell system is intimately connected to the nervous system, the gut, the immune system and connective tissue, so when it is dysregulated, multiple body systems are affected — and leaving any of them untreated can keep mast cell activation going indefinitely. These are the clusters an integrative assessment looks for and manages together:
EDS & joint hypermobility
Approximately 1 in 3 patients with MCAS have a comorbid hypermobile EDS diagnosis, and in studies of patients with both POTS and EDS, 66% also meet criteria for MCAS. Shared mast cell, connective tissue and autonomic biology is now well documented.
POTS & dysautonomia
POTS and MCAS frequently co-occur. Around 31% of patients with combined POTS and EDS have MCAS, compared with just 2% in matched controls — an odds ratio of around 32. The autonomic and immune systems are deeply intertwined.
Fibromyalgia, chronic pain & fatigue
Mast cells release histamine, tryptase and inflammatory cytokines that sensitise pain pathways, making MCAS a hidden driver of fibromyalgia in many people. Post-viral MCAS is increasingly recognised in ME/CFS and long COVID, where mast cell over-activation drives much of the fatigue, brain fog and inflammation.
Gut, mood & neurodivergence
Many MCAS patients have IBS-like symptoms, reflux and food intolerances, because mast cells line the gut and drive hypersensitivity and dysmotility. Histamine and mast cell mediators also drive neuroinflammation that contributes to anxiety and low mood, and there is increasing evidence linking mast cell over-activation to autism and ADHD — recent research suggests MCAS may be present in up to 17% of autistic individuals. Where relevant we weave this into one plan and link to our neurodivergence pathway. Mast cells are also involved in endometriosis and many patients flare around their menstrual cycle, perimenopause or with hormone changes.
MCAS and functional medicine testing
What we find
In MCAS, functional testing is often the difference between successful treatment and going round in circles. We test for hidden mast cell triggers including mould and mycotoxin exposure, stealth infections, gut dysbiosis (SIBO, methanogen and fungal overgrowth), increased intestinal permeability, methylation pathway errors that affect histamine clearance, DAO enzyme function, and the micronutrient deficiencies that affect immune regulation.
What we commonly see work
Because MCAS patients are so sensitive to interventions, an integrative approach measures before it prescribes. Testing is optional, but where it is used it lets us target the real underlying triggers rather than guessing — which tends to mean faster, cleaner results with fewer reactions. Treatment normally combines supplements, therapeutic diets and, in some cases, medications, sequenced carefully to your level of sensitivity.
MCAS diet and the gut microbiome
What we find
The gut microbiome and mast cells are intimately connected — gut bacteria directly modulate mast cell behaviour, and mast cells in the gut wall in turn affect the microbiome. Most MCAS patients have significant dysbiosis, often with an overgrowth of histamine-producing bacteria, SIBO, increased intestinal permeability and multiple food intolerances, all of which keep the histamine load high.
What we commonly see work
A tailored low-histamine diet is the cornerstone of MCAS dietary therapy, reducing the load on a system that cannot keep up with clearance. There is no single “MCAS diet” that works for everyone, so we adapt it to your specific triggers. Crucially, restoring microbiome balance, repairing the gut barrier and reducing histamine-producing organisms is one of the highest-yield interventions in MCAS — it often dramatically reduces the need for symptomatic medication over time. Restriction is always temporary and goal-driven, with careful expansion of tolerated foods as the mast cells stabilise.
Nervous system and mindbody medicine for MCAS
What we find
The autonomic nervous system is one of the most important triggers for mast cell activation — stress hormones and sympathetic activation directly cause mast cells to release their mediators. This is why so many people with MCAS notice that stress, poor sleep and sensory overload set off flares, and why the condition can feel like it feeds on its own anxiety. Diaphragm dysfunction and sensory processing overload are both common and both feed into mast cell triggering.
What we commonly see work
Nervous system regulation is not optional in MCAS — it is foundational. Using the bi-directional brain-body link, we work to bring the autonomic nervous system out of chronic sympathetic dominance with vagal nerve stimulation, biofeedback, limbic system retraining and audio entrainment, alongside structured work on diaphragm dysfunction. Practices that activate the “relaxation response” (which Dr Gordon studied at Harvard with Dr Herbert Benson) are tailored to be easy to sustain, since many people have tried these tools before without a system and not noticed a benefit. Calming the nervous system directly reduces one of the biggest ongoing drivers of mast cell activation.
Activity, pacing and rehabilitation for MCAS
What we find
Movement matters in MCAS, but it has to be handled carefully. Exertion can itself trigger mast cell mediator release, and where POTS and fatigue overlap, pushing too hard can provoke flares, dizziness and post-exertional crashes that set recovery back for days. Generic exercise advice often backfires as a result, and long periods of avoidance lead to deconditioning that makes symptoms worse again.
What we commonly see work
The goal is gentle, graded activity paced to your body rather than pushed — often starting with recumbent or low-histamine-trigger movement, electrolyte and fluid support where POTS features, and gradual progression as mast cells stabilise. Rehabilitation is coordinated with the rest of the plan, so autonomic symptoms, fatigue and reactivity are being addressed at the same time as movement rather than in isolation.
Supplements and nutraceuticals for MCAS
What we find
The right nutraceuticals can stabilise mast cells and support the pathways that clear histamine, but form and brand matter enormously in MCAS.
What we commonly see work
Each person’s regimen is different, but it may include:
- Many people with MCAS are intolerant to most supplements. In these cases we start with ultra-low microdose supplements from specific formulations and brands to reduce triggers as much as possible, then successfully integrate each single-ingredient supplement one at a time.
- Mast cell stabilising nutraceuticals such as quercetin, luteolin and perilla
- DAO enzyme support to help break down dietary histamine
- Methylation support to aid histamine clearance, matched to your pathway
- Mitochondrial support for the fatigue and brain fog that often accompany MCAS
- Gut barrier repair and targeted microbiome support
- Nutrients that support detoxification, matched to functional testing
We use specifically tolerated, clinical-grade brands and introduce one thing at a time, so that if a reaction does occur we know exactly what caused it.
Medication management for MCAS
What we find
Most people with MCAS are very sensitive to medication side effects, and reactions to a drug’s formulation — rather than the active ingredient — are common. This is exactly why a personalised, carefully titrated approach matters, rather than a fixed protocol applied to everyone.
What we commonly see work
We use proven MCAS medication protocols — typically building H1 and H2 antihistamines and mast cell stabilisers in a careful sequence — personalised to each patient’s level of sensitivity and their specific subsymptoms, with close attention to formulation choice and slow titration to minimise adverse reactions. Because integrative medicine is still medicine, repurposed options such as low-dose naltrexone can be considered where indicated, and POTS, gut and mood medications can all be coordinated within one plan rather than scattered across separate clinics.
Your environment and MCAS
What we find
Environment is not a side issue in MCAS — for many people it is central. Hidden mould and water damage in the home is one of the most common perpetuating triggers we uncover, and everyday exposures such as fragranced products, harsh cleaning chemicals and poor air quality can keep an already over-reactive mast cell system on high alert.
What we commonly see work
- Investigating and remediating sources of mould and water damage in the home
- Removing fragranced products and harsh chemical cleaners that act as triggers
- Air purifiers and improved indoor air quality to reduce the overall load
- Reducing dust and other reservoirs of triggers in the sleeping environment
- Limiting bright light in the evening and protecting sleep, since poor sleep drives flares
- Introducing any new element — including saunas or cold exposure — gradually and only after discussing with your doctor
Reducing the environmental trigger load often makes every other part of the plan work better.
MCAS across the lifespan
Mast cell activation can affect people at any age, and it presents differently across the lifespan. In adults, it often surfaces or worsens after a viral illness, a period of high stress, or alongside long-standing hypermobility and dysautonomia. In teenagers, it can emerge during the physical and hormonal changes of puberty, sometimes alongside anxiety, gut symptoms and fatigue that are easy to misattribute. In children, allergic-type reactions, tummy troubles and food sensitivities may be the first clues, and careful, gentle assessment matters most. Our adult service focuses on those aged 18 and over; younger patients are supported through our dedicated children’s and teens’ pathways, so families can be seen across the whole age range.
What an integrative plan can look like
Rachel’s story
Rachel, a 38-year-old teacher, developed unexplained flushing, hives, gut reactions and severe fatigue after a COVID infection. By the time she reached our clinic she was reacting to over 50 foods, could not tolerate scented products or many medications, was sleeping poorly, and was off work on long-term sick leave. Her GP had told her she had “post-viral anxiety” and recommended an SSRI, which she could not tolerate.
Rachel had self-diagnosed MCAS after months of research. She also had a long-standing pattern of joint hypermobility, dizziness on standing and food intolerances that pre-dated COVID — suggesting a likely background of hEDS and dysautonomia that the infection had tipped into full MCAS. Following an integrative assessment, we confirmed likely MCAS and probable hEDS clinically. Functional testing showed mould exposure (later confirmed as water damage in her flat), gut dysbiosis and a methylation error affecting histamine clearance.
Rachel was started on a carefully sequenced MCAS medication protocol, targeted mast cell stabilising nutraceuticals, a tolerable low-histamine diet, low-dose cannabinoid oil, mould remediation steps, mitochondrial support, and a daily vagal toning practice. At 9 months she was tolerating around 80 foods, her flushing and hives had largely resolved, her energy had improved significantly and she had returned to part-time teaching. By 12 months she was on maintenance treatment, working full-time and gradually expanding her diet further — no longer afraid of her own immune system.
Illustrative case based on the typical patient journey we see at the clinic; identifying details have been changed to protect privacy. Individual results vary.
Frequently asked questions
MCAS cannot be cured, but symptoms can be substantially improved with an integrative, whole-system approach — identifying and removing hidden triggers, a personalised low-histamine diet and gut repair, mast cell stabilising nutraceuticals, nervous system regulation and environment work — used alongside carefully managed medication rather than instead of it.
For some people, yes. cannabinoid medicine is a legal, specialist-prescribed medicine that works through the endocannabinoid system and has a mast cell stabilising effect. Used at low doses with carefully chosen formulations, it can help with the sleep, anxiety, pain and gut symptoms that travel with MCAS. It is one personalised option within a wider plan, never used in isolation.
We combine a detailed history with functional testing for the common hidden drivers — mould and mycotoxins, stealth infections, gut dysbiosis, methylation and DAO enzyme errors, and micronutrient status — and then reduce the trigger load step by step. Because reactions are so individual, we change one thing at a time so it is clear what is helping.
Yes — this is central to the approach. Because MCAS, POTS and hypermobile EDS so often occur together as one connected picture, they are assessed for and managed as part of a single coordinated plan.
There is increasing evidence linking mast cell over-activation to neurodivergence via neuroinflammation, and MCAS appears to be more common in autistic and ADHD individuals. Where relevant we manage these together and can coordinate with our neurodivergence pathway.
Yes. Our adult integrative service sees patients aged 18 and over, and we have dedicated children’s and teens’ pathways, so families can be supported across the lifespan. Please contact the clinic and we will direct you to the right pathway.
Integrative medicine, delivered by specialist doctors
- One plan for everything that travels together. MCAS, POTS, EDS, gut, fatigue and neurodivergence managed by one team, not scattered across clinics that never speak.
- Specialist medical doctors only. Every consultation is with an integrative medical doctor who can prescribe and investigate, not a fixed protocol.
- A genuinely integrative toolbox. Functional medicine, cannabinoid medicine, nutrition, nervous system work and environment, stacked for a synergistic effect.
- Low and slow, for sensitive bodies. We start lower, escalate slower, and prepare the ground first — which is exactly what MCAS needs.
Dr Dani Gordon, MD
Medical Director & Founder, London Resilience Clinic
Dr Dani Gordon, MD is a double board-certified medical doctor and world-leading authority in integrative medicine. She is the UK’s most experienced cannabinoid medicine doctor, a published researcher and author, with over 17 years of integrative and functional medicine experience treating complex chronic illness and neurodivergence — including ASD, ADHD, AuDHD and associated conditions — in children and adults.
UK General Medical Council (GMC) licence no. 7818491